Hypertensive retinal changes, a screening tool to predict microalbuminuria in hypertensive patients: A cross-sectional study

Nephrology Dialysis Transplantation

Volumn 25, Issue 6, 2010, Pages 1839-1845

  Shantha, Ghanshyam Palamaner Subash ^a   Kumar, Anita Ashok ^b   Bhaskar, Emmanuel ^a   Sivagnanam, Kamesh ^a   Srinivasan, Devasena ^a   Sundaresan, Manjunath ^a   Arthur, Preetam ^a   Abraham, Georgi ^c  

^a SRI RAMACHANDRA UNIVERSITY   (India)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MADRAS MEDICAL MISSION HOSPITAL   (India)

Author keywords

Albuminuria; Chronic inflammation; Clinical hypertension; Clinical nephrology; Microalbuminuria

Indexed keywords

ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EYE FUNDUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; RETINA DISEASE; SENSITIVITY AND SPECIFICITY; SPOT URINE; URINALYSIS;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; INDIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETINA; RISK FACTORS; YOUNG ADULT;

EID: 77952977870     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp726     Document Type: Article

References (40)

1. Blythe WD, Maddux FW. Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980-1986. Am J Kidney Dis 1991; 28: 33-37
2. Prakash J, Hota JK, Singh S et al. Clinical spectrum of chronic renal failure in the elderly: a hospital based study from eastern India. Int Urol Nephrol 2006; 38: 821-827
3. Mani MK. Prevention of chronic renal failure at the community level. Kidney Int 2003; 63: S86-S89
4. Yudkin JS, Forrest RD, Jackson C. Microalbuminuria as predictor of vascular disease in non diabetic subjects. Lancet 1988; 2: 530-533
5. Damsgaard EM, Froland A, Jorgensen OD et al. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300: 297-300
6. Shantha GP, Bhaskar E, Kumar AA et al. Accuracy of retinal changes in predicting microalbuminuria among elderly hypertensive patients: a cross-sectional study from a teaching hospital in South India. Int Urol Nephrol 2009; 41: 137-143
7. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29: S43-S48
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of high Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
9. Chobanian AV, Bakris GL, Black HR et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC-7). JAMA 2003; 289: 2560-2571
10. Jeffrey SF, Eleftheria MF. Obesity. In: DL Kasper, E Braunwald, AS Fauci, SL Hauser, DL Longo, JL Jameson (eds). Harrison's Principles of Internal Medicine. Vol 1, 16th edition. New York: McGraw-Hill Inc., 2005; 422-423
11. Poulsen PL, Mogensen C. Clinical evaluation of a test for immediate and quantitative determination of urinary albumin to creatinine ratio. Diabetes Care 1998; 21: 97-98
12. Hoy W, McDonald Sp. Albuminuria: marker or target in indigenous populations. Kidney Int Suppl 2004; 92: S25-S31
13. Tetsuya B, Chieko T, Yasuhiko I et al. Definition of microalbumi-nuria in first-morning and random spot urine in diabetic patients. Diabetes Care 2004; 27: 1838-1839
14. Romhilt DW, Estes EH Jr. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 1968; 75: 752-758
15. Levey AS, Coresh J, Greene T et al. Using standardized serum cre-atinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254
16. Keith NM, Wagner HP, Barker NW. Some different types of essential hypertension\their course and prognosis. Am J Med Sci 1939; 197: 332-343
17. Greenberg RS, Daniels SR, Dana Flanders W et al. Diagnostic testing. In: RS Greenberg (ed). Medical Epidemiology. New York: McGraw-Hill, 2005
18. Ruilope LM, Salvetti A, Jamerson K et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 2001; 2: 218-225
19. Mann JF, Gerstein HC, Pogue J et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629-636
20. Pontremoli R, Sofia A, Ravera M et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC study. Hypertension 1997; 30: 1135-1143
21. Pan CY, Ho LT, Soegondo S et al. Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective. Diabetes Technol Ther 2008; 10: 397-403
22. Hoegholm A., Bang EL, Kjeld S. et al. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension 1994; 24: 101-105
23. Andronico G, Romé M, Lo Cicero A et al. Renal plasma flow, filtration fraction and microalbuminuria in hypertensive patients: effects of chronic smoking. Nephrology (Carlton) 2005; 10: 483-486
24. Jager A, Kostense PJ, Ruhé HG et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617-624
25. Kronenberg F, Kuen E, Ritz E et al. Lipoprotein (a) serum concentrations and apolipoprotein (a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 2000; 11: 105-115
26. Fliser D, Pacini G, Engelleiter R et al. Insulin resistance and hyper-insulinemia are already present in patients with incipient renal disease. Kidney Int 1998; 53: 1343-1347
27. Jungers P, Joly D, Massy Z et al. Sustained reduction of hyperhomo-cysteinaemia with folic acid supplementation in predialysis patients. Nephrol Dial Transplant 1999; 14: 2903-2906
28. Sciarretta S, Pontremoli R, Rosei EA et al. Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness onMicroAlbuminuria in patients with hypertensive Disease study. J Hypertens 2009; 27: 410-417
29. van den Born BJ, Hulsman CA, Hoekstra JB et al. Value of routine funduscopy in patients with hypertension: systematic review. Br Med Jr 2005; 331: 73-77
30. Cuspidi C, Meani S, Valerio C et al. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study. Blood Press 2005; 14: 25-31
31. Ebinc H, Ebinc FA, Ozkurt ZN. Relationship of early hypertensive retinopathy to inflammation markers and microalbuminuria in hypertensive patients with regulated blood pressure. Saudi Med J 2007; 28: 472-473
32. Cuspidi C, Meani S, Salerno M et al. Retinal microvascular changes and target organ damage in untreated essential hypertensives. J Hy-pertens 2004; 22: 2095-2102 (Pubitemid 39463801)
33. Saitoh M, Matsuo K, Nomoto S et al. Relationship between left ventricular hypertrophy and renal and retinal damage in untreated patients with essential hypertension. Intern Med 1998; 37: 576-580
34. Sabanayagam C, Tai ES, Shankar A et al. Retinal arteriolar narrowing increases the likelihood of chronic kidney disease in hypertension. J Hypertens 2009 717 [Epub ahead of print]
35. Sabanayagam C, Shankar A, Koh D et al. Retinal microvascular caliber and chronic kidney disease in an Asian population. Am J Epidemiol 2009; 169: 625-632
36. Sun C, Wang JJ, Mackey DA et al. Retinal vascular caliber: systemic, environmental, and genetic associations. Surv Ophthalmol 2009; 54: 74-95
37. McGeechan K, Liew G, Macaskill P et al. Meta-analysis: retinal vessel caliber and risk for coronary heart disease. Ann Intern Med 2009; 151: 404-413
38. McGeechan K, Liew G, Macaskill P et al. Risk prediction of coronary heart disease based on retinal vascular caliber (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol 2008; 102: 58-63
39. Wong TY, Klein R, Couper DJ et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 2001; 358: 1134-1140
40. Puttinger H, Soleiman A, Oberbauer R. Regression of hypertensive nephropathy during three years of optimal blood pressure control. Wien Klin Wochenschr 2003; 115: 429-431